ECC-5004
ECC-5004 (Compound 1) is a GLP-1 receptor agonist with an EC50 of 0-20 nM. ECC-5004 exhibits strong inhibitory effects on OATP1B1, with an IC50 [1].
Product Specifications
UNSPSC
12352005
Target
GLP Receptor
Related Pathways
GPCR/G Protein
Field of Research
Metabolic Disease
Smiles
CC1=CC(N2N=C3CCN([C@H](C3=C2N4C=CN(C4=O)C5=C(C6=C(N(N=C6)C)C=C5)F)C)C(C7=C(N8C=CC([C@H]9CCOC(C)(C9)C)=CC8=C7)[C@]%10(C[C@@H]%10C)C%11=NOC(N%11)=O)=O)=CC(C)=C1F
Molecular Formula
C48H48F2N10O5
Molecular Weight
882.96
References & Citations
[1]Zaifang REN, et al. Tetrahydropyrazolo-pyrazinyl-dihydroimidazolone or tetrahydropyrazolo-pyridinyl-dihydroimidazolone compounds and methods of using same. WO2022017338A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
